Signing of a Patent License Agreement with Tufts Medical Center to jointly advance the development of tafenoquine for babesiosis treatment, indicating a strategic collaboration that enhances the ...
ON 18 December, 2024, the World Health Organization (WHO) prequalified the first diagnostic test for glucose-6-phosphate dehydrogenase (G6PD) deficiency, ...